The Glucosamine Controversy; A Pharmacokinetic Issue

by Ali Aghazadeh-Habashi, Fakhreddin Jamali
Published 2011-06-01

The Impact of Implementation of the Canadian Regulatory Requirements on the Quality of Natural Health Products: The Glucosamine Case

by Ali Aghazadeh-Habashi, John Duke, Fakhreddin Jamali
Published 2014-02-01

Tissue Engineering Through 3D Bioprinting to Recreate and Study Bone Disease

by Adriene Pavek, Christopher Nartker, Maamoon Saleh, Matthew Kirkham, Sana Khajeh Pour, Ali Aghazadeh-Habashi, Jared J. Barrott
Published 2021-05-01